Partner Headlines - IBB

  1. ProShares Releases 2 New Leveraged Biotech ETFs

    Benzinga
  2. Biotech ETFs Hit New 2015 Highs

    Benzinga
  3. Investment Strategies for the Bullish Biotech Sector

    GuruFocus
  4. 'Don't Give Up On Biotech Yet,' Says This CFA

    Benzinga
  5. Making Money With Charles Payne: 05/1/15

    FoxBusiness
  6. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD
  7. Technology, Inflation Protection And Biotech ETFs To Watch This ...

    Benzinga
  8. How To Invest In ETFs: Tips To Trade Top Market Trends

    IBD
  9. Social Media Analytics: 3 ETFs Recently Blowing Up On Twitter

    Benzinga
  10. The Best Biotech ETF Isn't Always The Biggest

    Benzinga
  11. Biotech Stocks Moving Higher

    Benzinga
  12. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga
  13. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga
  14. iShares NASDAQ Biotech ETF Pulls Back Off All-Time Highs

    Benzinga
  15. Making Money With Charles Payne: 01/14/15

    FoxBusiness
  16. Are There Any Winners Left In The Biotech Space?

    Benzinga
  17. Biotech Stocks Sell Off, ETFs Fall Over 5%

    Benzinga
  18. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  19. 3 Biotech ETFs Rally On Merger News

    Benzinga
  20. A Look At 3 Overbought ETFs

    Benzinga
  21. 1 Biotech Beast Worth Tracking

    Benzinga
  22. Best And Worst ETFs Of The Week Amid Biotech Breakout

    Benzinga
  23. Arrowhead Research Corp Heads Higher After Breakout

    Benzinga
  24. Biotechnology, Oil And Brazil ETFs To Watch This Week

    Benzinga
  25. Isis Pharmaceuticals Finally Breaks Out

    Benzinga
  26. Yellen Says Social Media, Biotech Stocks 'Substantially Stretched'

    Benzinga
  27. 4 ETFs With Upside Potential

    Benzinga
  28. Dow Closes At A New High As Late-Month Rally Boosts Stocks

    Benzinga
  29. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  30. Stocks Revisit Session Lows; Share Offer Lifts GasLog

    IBD
  31. Don't Panic Over Recent Tech Turmoil

    FoxBusiness
  32. Despite S&P 500's New High, Stocks Face Challenges

    Benzinga
  33. Biotech ETFs Come Back Down To Earth

    Benzinga
  34. ETF Outlook For Wednesday, March 26, 2014 (IBB, IPO, FPX, SOCL, ...

    Benzinga
  35. ETF Outlook For The Week Of March 24, 2014 (IBB, CARZ, RSX, GM)

    Benzinga
  36. Stocks Edge Lower In Dull Session; Biogen Idec Hangs Tough

    IBD
  37. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  38. Biotech And Natural Gas ETFs On A Roll

    Benzinga
  39. ETF Outlook For The Week Of February 10 (IBB, VXZ, GREK, GDX)

    Benzinga
  40. Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY)

    Benzinga
  41. ETF Outlook for Friday, December 20 (REM, USO, IBB, FCG)

    Benzinga
  42. The One True Sector Bubble: Profits Here When It Crashes Soon

    Benzinga
  43. ETF Outlook for Tuesday, November 26, 2013

    Benzinga
  44. Biotech ETFs Plummeting (XBI, IBB, BBH)

    Benzinga
  45. Biotech Breakout Highlights Flawed ETF Thinking

    Benzinga
  46. Three Soaring, But Overlooked Health Care ETFs

    Benzinga
  47. Seasonal Trends: Three ETFs To Own In August

    Benzinga
  48. Three ETFs That Have Blown Past Their 200-Day Lines

    Benzinga
  49. ETFs to Watch July 29, 2013 (BOND, EWJ, IBB)

    Benzinga
  50. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  51. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  52. Use The Sharpe Ratio For Profits With These ETFs

    Benzinga
  53. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga
  54. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
  55. These ETFs Are Awash in 2013 Takeover Targets

    Benzinga
  56. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga
  57. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga
  58. S&P Likes a Trio of Biotech ETFs

    Benzinga
  59. ETFs to Watch October 23, 2012 (FCF, IBB, EWT)

    Benzinga
  60. Investors Cheating Themselves by Focusing on Largest ETFs

    Benzinga
  61. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  62. When Cheaper Is Better With ETFs

    Benzinga
  63. Possible Hepatitis C Outbreak Could Lift This ETF

    Benzinga
  64. Low Volume, High Returns for These ETFs (BIB, FHC, DRW)

    Benzinga
  65. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga
  66. ETFs to Watch July 3, 2012 (TNA, XLB, PCY)

    Benzinga
  67. Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)

    Benzinga
  68. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga
  69. 4 High P/E ETFs (IBB, IGV, PNQI)

    Benzinga
  70. S&P Bullish On Biotech ETFs (FBT, IBB, XBI)

    Benzinga
  71. 4 Ignored ETFs Up More Than 20% YTD (GERJ, VROM, TAO)

    Benzinga
  72. Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)

    Benzinga
  73. 10 ETFs That Should Lower Their Expense Ratios

    Benzinga
  74. Friday Slide: Opportunity Or Red Flag For Biotech ETFs? (GILD, ...

    Benzinga
  75. ETFs to Watch February 13, 2012

    Benzinga
  76. ETFs to Watch February 8, 2012

    Benzinga
  77. ETFs to Watch January 5, 2012

    Benzinga
  78. Twelve For '12: Sector ETFs to Watch In The New Year

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!